Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,935
Closed -$853K 111
2023
Q4
$853K Buy
11,935
+60
+0.5% +$4.18K 0.55% 69
2023
Q3
$824K Buy
11,875
+549
+5% +$41.5K 0.59% 67
2023
Q2
$917K Sell
11,326
-95
-0.8% -$7.76K 0.64% 67
2023
Q1
$922K Buy
+11,421
New +$919K 0.7% 65

Other funds holding HOLX

Argus Investors Counsel's HOLX Position: Q1 2024 in Review

Argus Investors Counsel sold out of Hologic (HOLX) in Q1 2024, closing a stake of 11,935 shares — an estimated $853K sold.

Argus Investors Counsel first reported a position in HOLX in Q1 2023 and held it in 4 quarters. The position peaked at $922K in Q1 2023. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2024.

  • Argus Investors Counsel reported no remaining Hologic position as of Q1 2024 after selling out during the quarter.
  • Argus Investors Counsel sold 11,935 Hologic shares in Q1 2024, an estimated $853K.
  • Argus Investors Counsel first reported a position in Hologic in Q1 2023 and held it in 4 quarters.
  • Argus Investors Counsel's Hologic position peaked at $922K in Q1 2023.
  • 706 funds tracked by Wall St. Rank held Hologic as of Q1 2024.

Based on Argus Investors Counsel's 13F filing for Q1 2024, filed 25 Apr 2024.